An inhibitor from placenta specifically binds urokinase and inhibits plasminogen activator released from ovarian carcinoma in tissue culture
- 1 November 1978
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 544 (1) , 128-137
- https://doi.org/10.1016/0304-4165(78)90216-7
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Arrest of growth of ovarian tumor by tranexamic acidJAMA, 1977
- Treatment of Advanced Breast Cancer with Chemotherapeutics and Inhibition of Coagulation and FibrinolysisActa Medica Scandinavica, 1977
- Purification of urokinase by affinity chromatographyBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Immunological identity of urokinase and ovarian carcinoma plasminogen activator released in tissue cultureNature, 1976
- Identification of an active site histidine in urokinaseBiochimica et Biophysica Acta (BBA) - Enzymology, 1976
- Inhibition of plasminogen activators by naturally occurring inhibitors in manAmerican Journal of Physiology-Legacy Content, 1972
- Studies on Fibrinolytic Inhibitors During PregnancyPublished by Wiley ,1971
- Partial Purification and Properties of Urokinase Inhibitor from Human PlacentaThe Journal of Biochemistry, 1970
- Urokinase Inhibitor in Human PlacentaNature, 1967
- Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodiesAnalytical Biochemistry, 1966